Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Doehn

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Aktuelle Urologie|November 24, 2022
Christian Doehn
European Urology|February 6, 2008
Immunotherapy of prostate cancerChristian Doehn
The Journal of Urology|September 6, 2006
Re: a clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinomaChristian Doehn
Aktuelle Urologie|August 10, 2019
[50 years of renal cell carcinoma]Christian Doehn
The Journal of Urology|April 28, 2009
Re: Genitofemoral nerve injury after laparoscopic varicocelectomy in adolescents. O. J. Muensterer. J Urol 2008; 180: 2155-2158Christian Doehn
Deutsches Arzteblatt International|March 30, 2017
In ReplyChristian Doehn, Steffen Weikert
Aktuelle Urologie|August 24, 2021
[Renal Cell Cancer]Inga Peters, Christian Doehn
Nature Clinical Practice. Urology|November 13, 2008
Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer?Christian Doehn, Dieter Jocham
Current Opinion in Molecular Therapeutics|November 19, 2002
Technology evaluation: PROSTVAC, TherionChristian Doehn, Dieter Jocham
Current Opinion in Molecular Therapeutics|February 25, 2003
Technology evaluation: MLN-591, Cornell University/BZL Biologics/ImmunoGen/MillenniumChristian Doehn, Dieter Jocham
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Aktuelle Urologie|November 24, 2022
Christian Doehn
European Urology|February 6, 2008
Immunotherapy of prostate cancerChristian Doehn
The Journal of Urology|September 6, 2006
Re: a clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinomaChristian Doehn
Aktuelle Urologie|August 10, 2019
[50 years of renal cell carcinoma]Christian Doehn
The Journal of Urology|April 28, 2009
Re: Genitofemoral nerve injury after laparoscopic varicocelectomy in adolescents. O. J. Muensterer. J Urol 2008; 180: 2155-2158Christian Doehn
Deutsches Arzteblatt International|March 30, 2017
In ReplyChristian Doehn, Steffen Weikert
Aktuelle Urologie|August 24, 2021
[Renal Cell Cancer]Inga Peters, Christian Doehn
Nature Clinical Practice. Urology|November 13, 2008
Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer?Christian Doehn, Dieter Jocham
Current Opinion in Molecular Therapeutics|November 19, 2002
Technology evaluation: PROSTVAC, TherionChristian Doehn, Dieter Jocham
Current Opinion in Molecular Therapeutics|February 25, 2003
Technology evaluation: MLN-591, Cornell University/BZL Biologics/ImmunoGen/MillenniumChristian Doehn, Dieter Jocham
Pageof 7